Evofem Biosciences Inc

NASDAQ:EVFM  
0.42
-0.01 (-1.67%)
4:01:33 PM EDT: $0.42 0.00 (-0.66%)
Other Pre-Announcement

Evofem Biosciences Expects Record High Phexxi Prescriptions And Strong Net Revenue Growth In Fourth Quarter 2021

Published: 12/09/2021 13:23 GMT
Evofem Biosciences Inc (EVFM) - Evofem Biosciences Expects Record High Phexxi Prescriptions and Strong Net Revenue Growth in Fourth Quarter 2021.
Evofem Biosciences Inc - Expect to Meet Or Exceed Current Analyst Consensus Estimate of Net Revenue in Q4.
Evofem Biosciences Inc - Reducing Quarterly Net Cash Burn Rate and Expect It Will Decrease by at Least $10 Million From Q3 Levels Starting in Q4.